基本信息
浏览量:455
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Dr. Pal holds patents for new drugs currently under development in prostate cancer and also maintains one of the largest portfolios of clinical trials for kidney and bladder cancer research on the West Coast. He developed an integrated program that focuses heavily on collaborations with basic science researchers at the Beckman Research Institute of City of Hope and urologists in the Department of Surgery. Ultimately, Dr. Pal’s goal is to stimulate collaborative research across multiple departments in order to discover novel therapeutic approaches for currently incurable diseases. He has also worked to push the boundaries of personalized medicine in genitourinary cancers with several seminal publications in rare genitourinary cancers that describe unique therapeutic targets. He is the lead investigator on multiple trials, ranging from early phase 1 experiences to late stage phase 3 studies.
研究兴趣
论文共 1025 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meetingno. 2 (2024): e430428-e430428
ONCOLOGISTno. 3 (2024): 254-262
Nutrientsno. 11 (2024): 1630
Lyndsey Griffin,Latha Shivakumar,Leigh Boehmer, Savannah Dodson,Elana Plotkin,Sumanta Pal,Al B. Benson
Cancer Researchno. 6_Supplement (2024): 999-999
Nature medicinepp.1-10, (2024)
NATURE MEDICINE (2024)
Journal of Clinical Oncologyno. 16_suppl (2024): 1038-1038
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn